Recursion Appoints Fred Hassan As Board Chair, Effective Oct. 31

Benzinga · 2d ago

Recursion (Nasdaq: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development, today announced that its Board of Directors has appointed Fred Hassan as Chair, effective October 31, 2026